Astrocyte Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Astrocyte Pharmaceuticals has raised $15.6M across 3 funding rounds on record, the most recent a Series B of $9.5M announced in Sep 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Astrocyte Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Astrocyte Pharmaceuticals Funding Rounds
Astrocyte Pharmaceuticals raised $6.0M in a Series B announced in Aug 2023.
1.3 years later, an undisclosed round of $110k was announced in Dec 2024.
1.8 years later, a Series B of $9.5M was announced in Sep 2026.
Astrocyte Pharmaceuticals Investors
29 investors are recorded in total; the 5 named above are those the record identifies.
Astrocyte Pharmaceuticals Founders and Leadership Team
Contact details for the Astrocyte Pharmaceuticals team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Astrocyte Pharmaceuticals Funding Compared to Other Biotechnology Startups
Astrocyte Pharmaceuticals' latest round of $9.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Astrocyte Pharmaceuticals in Biotechnology and Cambridge
Companies Similar to Astrocyte Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Astrocyte Pharmaceuticals Funding FAQs
What does Astrocyte Pharmaceuticals do?
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
How much funding has Astrocyte Pharmaceuticals raised?
Astrocyte Pharmaceuticals has raised $15.6M across 3 rounds on record. The most recent is a Series B of $9.5M announced in Sep 2026.
When did Astrocyte Pharmaceuticals last raise funding?
Astrocyte Pharmaceuticals' most recent funding round on record is a Series B of $9.5M, announced in Sep 2026.
Who has invested in Astrocyte Pharmaceuticals?
Investors on record for Astrocyte Pharmaceuticals include DeepWork Capital, Navis Capital Partners, National Institutes of Health, Angel Star Ventures, Alzheimer's Drug Discovery Foundation. FundedIQ records 29 investors in total.
Who founded Astrocyte Pharmaceuticals?
FundedIQ lists James Lechleiter (Founder), William Korinek (Founder) at Astrocyte Pharmaceuticals.
Where is Astrocyte Pharmaceuticals headquartered?
Astrocyte Pharmaceuticals is based in Cambridge, Massachusetts, United States.
How many employees does Astrocyte Pharmaceuticals have?
Astrocyte Pharmaceuticals is in the 1-10 employee band.
When was Astrocyte Pharmaceuticals founded?
Astrocyte Pharmaceuticals was founded in 2014.
How does Astrocyte Pharmaceuticals' funding compare to other Biotechnology startups?
Astrocyte Pharmaceuticals' latest round of $9.5M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Astrocyte Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Astrocyte Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.